← Back to Search

Dietary Supplement

Acute Beetroot Juice for High Blood Pressure

N/A
Waitlist Available
Led By Gregory Grosicki, PhD
Research Sponsored by Georgia Southern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Free from signs or symptoms of neurologic, cardiovascular (e.g., heart attack, stroke, heart failure, arrhythmia), metabolic, and/or renal disease
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-intervention)
Awards & highlights

Study Summary

This trial will test whether beetroot juice can help lower blood pressure and improve vascular health in Black adults by increasing nitric oxide availability.

Eligible Conditions
  • High Blood Pressure
  • Racial Disparities
  • Cardiovascular Risk

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You do not have any problems with your brain, heart, metabolism, or kidneys, and you are not experiencing any related symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in arterial stiffness
Changes in arterial stiffness responses to stress
Changes in blood pressure
+2 more
Secondary outcome measures
Economic determinants of health
Habitual dietary intake
Objective sleep duration
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Nitrate-rich beetroot juice (~12.8 mmol)Experimental Treatment1 Intervention
Participants will have blood pressure, arterial stiffness, and blood samples (from venipuncture) assessed before and after the nitrate-rich beetroot juice (~12.8 mmol).
Group II: Beetroot juice with nitrate removedPlacebo Group1 Intervention
Participants will have blood pressure, arterial stiffness, and blood samples (from venipuncture) assessed before and after the beetroot juice with nitrate removed.

Find a Location

Who is running the clinical trial?

Georgia Southern UniversityLead Sponsor
7 Previous Clinical Trials
2,465 Total Patients Enrolled
Gregory Grosicki, PhDPrincipal InvestigatorGeorgia Southern University

Media Library

Beetroot Juice (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05132556 — N/A
High Blood Pressure Research Study Groups: Nitrate-rich beetroot juice (~12.8 mmol), Beetroot juice with nitrate removed
High Blood Pressure Clinical Trial 2023: Beetroot Juice Highlights & Side Effects. Trial Name: NCT05132556 — N/A
Beetroot Juice (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05132556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept participants who are octogenarians?

"This trial is only accepting individuals aged 18 to 39. Nevertheless, there are 8 studies available for minors and 141 separate trials catered towards senior citizens."

Answered by AI

What are the crucial aims of this research?

"This trial will assess arterial stiffness at Baseline and two hours after beetroot juice ingestion in both the experimental and control groups. Secondary objectives include an evaluation of participants' habitual dietary intake, social determinants of health, as well as their objective sleep duration which will be assessed using a combination of self-reported diary entries and actigraphy measurements taken over 7 days."

Answered by AI

Is this study open to recruitment at present?

"Per the official listing on clinicaltrials.gov, this medical investigation is presently recruiting patients with its initial post on November 1st 2021 and most recent update on August 1st 2022."

Answered by AI

Who is eligible to enroll in this investigation?

"The trial is targeting 40 individuals with a systolic blood pressure of 18-39, who are non-smokers in the last year, have BMI's below 30 kg/m^2 and remain free from neurological, cardiovascular (including heart attack or stroke), metabolic and renal diseases."

Answered by AI

How many participants are presently involved in this medical trial?

"Affirmative. Per the information found on clinicaltrials.gov, this medical inquiry is actively searching for participants to join their study as of August 1st 2022. The trial was first posted November 1st 2021 and requires 40 individuals from one location to participate."

Answered by AI
~12 spots leftby Mar 2025